Eli Lilly and Company (LLY) Wins FDA Nod For Once-Weekly Basal Insulin Onswik
Eli Lilly and Company received FDA approval for Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin for adults with type 2 diabetes. The pen will be available in the U.S. in coming months in U-500 and U-1,000 concentrations.Material DetailsContext by AI AnalystThis is a late-stage conf…